Capital Fund Management (CFM)’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $17.8M | Sell |
33,791
-9,098
| -21% | -$5.1M | 0.08% | 368 |
|
|
2026
Q1 | $24.1M | Sell |
42,889
-2,332
| -5% | -$1.5M | 0.11% | 253 |
|
|
2025
Q4 | $30.6M | Buy |
45,221
+31,715
| +235% | +$21.6M | 0.09% | 319 |
|
|
2025
Q3 | $8.63M | Buy |
13,506
+1,964
| +17% | +$1.19M | 0.02% | 917 |
|
|
2025
Q2 | $6.19M | Sell |
11,542
-8,714
| -43% | -$4.17M | 0.02% | 1009 |
|
|
2025
Q1 | $8.51M | Buy |
+20,256
| New | +$8.8M | 0.02% | 754 |
|
|
2024
Q4 | – | Sell |
-20,187
| Closed | -$10.2M | – | 2125 |
|
|
2024
Q3 | $10.2M | Buy |
20,187
+4,166
| +26% | +$2.02M | 0.03% | 720 |
|
|
2024
Q2 | $7.81M | Sell |
16,021
-26,943
| -63% | -$13.5M | 0.02% | 779 |
|
|
2024
Q1 | $23.2M | Buy |
42,964
+9,635
| +29% | +$5.27M | 0.07% | 384 |
|
|
2023
Q4 | $18.5M | Buy |
+33,329
| New | +$15.6M | 0.05% | 497 |
|
|
2023
Q3 | – | Sell |
-18,597
| Closed | -$9.27M | – | 2001 |
|
|
2023
Q2 | $9.34M | Buy |
+18,597
| New | +$8.91M | 0.04% | 587 |
|
|
2020
Q2 | – | Sell |
-954
| Closed | -$231K | – | 1272 |
|
|
2020
Q1 | $231K | Sell |
954
-9,627
| -91% | -$2.51M | ﹤0.01% | 1342 |
|
|
2019
Q4 | $2.76M | Buy |
10,581
+9,600
| +979% | +$2.53M | 0.02% | 743 |
|
|
2019
Q3 | $267K | Buy |
+981
| New | +$273K | ﹤0.01% | 1484 |
|
|
2019
Q2 | – | Sell |
-2,022
| Closed | -$498K | – | 1753 |
|
|
2019
Q1 | $452K | Sell |
2,022
-1,926
| -49% | -$398K | ﹤0.01% | 1289 |
|
|
2018
Q4 | $734K | Sell |
3,948
-5,300
| -57% | -$1.09M | 0.01% | 1217 |
|
|
2018
Q3 | $2.31M | Buy |
+9,248
| New | +$2.24M | 0.01% | 1045 |
|
|
2018
Q1 | – | Sell |
-150,167
| Closed | -$27.7M | – | 1989 |
|
|
2017
Q4 | $23.5M | Sell |
150,167
-37,500
| -20% | -$5.9M | 0.13% | 198 |
|
|
2017
Q3 | $29.2M | Buy |
187,667
+113,599
| +153% | +$18M | 0.21% | 142 |
|
|
2017
Q2 | $12M | Buy |
74,068
+68,400
| +1,207% | +$11.1M | 0.1% | 266 |
|
|
2017
Q1 | $876K | Buy |
5,668
+3,468
| +158% | +$478K | 0.01% | 972 |
|
|
2016
Q4 | $258K | Buy |
+2,200
| New | +$251K | ﹤0.01% | 1486 |
|
|
2015
Q3 | – | Sell |
-267,316
| Closed | -$17.1M | – | 1513 |
|
|
2015
Q2 | $17.1M | Buy |
267,316
+261,316
| +4,355% | +$18.1M | 0.22% | 120 |
|
|
2015
Q1 | $463K | Buy |
6,000
+3,200
| +114% | +$249K | 0.01% | 1074 |
|
|
2014
Q4 | $208K | Sell |
2,800
-96,958
| -97% | -$6.8M | ﹤0.01% | 1484 |
|
|
2014
Q3 | $5.88M | Buy |
+99,758
| New | +$6.31M | 0.07% | 364 |
|
Other funds holding IDXX
Capital Fund Management (CFM)'s IDXX Position: Q2 2026 in Review
Capital Fund Management (CFM) reduced its Idexx Laboratories (IDXX) stake by 21% in Q2 2026, selling an estimated $5.1M and leaving 33,791 shares worth $17.8M. The position accounts for 0.08% of the portfolio, ranked #368.
Capital Fund Management (CFM) first reported a position in IDXX in Q3 2014 and has held it in 26 quarters since. The position peaked at $30.6M in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Capital Fund Management (CFM) held 33,791 shares of Idexx Laboratories worth $17.8M as of Q2 2026.
- Capital Fund Management (CFM) sold 9,098 Idexx Laboratories shares in Q2 2026, an estimated $5.1M.
- Idexx Laboratories made up 0.08% of Capital Fund Management (CFM)'s portfolio in Q2 2026, its #368 holding.
- Capital Fund Management (CFM) first reported a position in Idexx Laboratories in Q3 2014 and has held it in 26 quarters since.
- Capital Fund Management (CFM)'s Idexx Laboratories position peaked at $30.6M in Q4 2025.
- 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.